Aaron Ondrey
Chief Financial Officer · ROCKET PHARMACEUTICALS, INC.
- 2025
- Jul 3, 2025
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Aaron Ondrey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Martin Wilson - $335K in RCKT purchases and sales in the last 12 months
- Gaurav Shah - $286K in RCKT purchases and sales in the last 12 months
- Christopher James Stevens - $128K in RCKT purchases and sales in the last 12 months
- Sarbani Chaudhuri - $84K in RCKT purchases and sales in the last 12 months
- Elisabeth Bjork - $34K in RCKT purchases and sales in the last 12 months
- John Militello - $24K in RCKT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Aaron Ondrey?
Aaron Ondrey is a corporate insider, tracked as Chief Financial Officer of ROCKET PHARMACEUTICALS, INC. (RCKT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Aaron Ondrey last file a Form 4?
The most recent primary Form 4 on record is dated 3 July 2025, one of 2 filings going back to 2025.
Has Aaron Ondrey been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($44K) across all tracked filings.
